医薬品開発を支えるパートナー
イーピーエス株式会社 (EPS Co., Ltd.) (eps.co.jp) scores 37 out of 100 on Brand Analyzer, placing it in the Early Stage tier among Healthcare brands, Other brands, in the 0th percentile of 16198 Healthcare brands.
イーピーエス株式会社 (EPS Co., Ltd.) is a group of extended play releases by an artist usually released at the same time with the same title and tracks but in different formats for consumption (digital, CD, LP). 医薬品・医療機器の開発に必要な業務を受託し、医療の発展に貢献する。.
| Brand Name | イーピーエス株式会社 (EPS Co., Ltd.) |
|---|---|
| Domain | eps.co.jp |
| Industry | Healthcare, Other |
| Main Competitors | シミック(CMIC) (43/100), IQVIA (85/100), パレクセル(PAREXEL) (89/100), リンクメッド(LinkMed), シンバイオ製薬サポート/EPSグループ以外のCRO:A2ヘルスケア, ラボコープ(Labcorp) (74/100) |
Moz Domain Authority 34/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,832,626 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "イーピーエスは、医薬品・医療機器の開発に必要な業務の受託機関です。" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram, GitHub; no detected presence on X (Twitter), Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is イーピーエス株式会社 (EPS Co., Ltd.)?", Claude could identify the brand as of October 2026. EPS Co., Ltd. is a Japanese contract research organization (CRO) that supports pharmaceutical and medical device companies with clinical trial management, data management, and regulatory affairs services. It is part of the EPS Holdings group, one of the major CROs in Japan's heal Best known for Being a leading Japanese CRO providing clinical trial support services to pharmaceutical companies.
When asked "Best brands similar to イーピーエス株式会社 (EPS Co., Ltd.)?", Claude would recommend イーピーエス株式会社 (EPS Co., Ltd.) as of October 2026. It's a well-established, major player in Japan's clinical research and pharmaceutical support industry, so it would naturally come up when discussing CROs in that market.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
イーピーエス株式会社 (EPS Co., Ltd.)'s main competitors in Healthcare: シミック(CMIC) (43/100), IQVIA (85/100), パレクセル(PAREXEL) (89/100), ラボコープ(Labcorp) (74/100).
Sources: Brand Analyzer scan
イーピーエス株式会社 (EPS Co., Ltd.) has low AI-search visibility, scoring 18/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 12, recommendation 27). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
イーピーエス株式会社 (EPS Co., Ltd.) scores 27/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
イーピーエス株式会社 (EPS Co., Ltd.) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
イーピーエス株式会社は、医薬品・医療機器の開発に必要な業務を受託するサービスを提供しています。具体的には、創薬支援、化合物管理を含む、医薬品・再生医療等製品の開発における幅広い専門サービスをワンストップで提供しており、研究開発から製品化までの各段階を包括的にカバーするフルソリューションを展開しています。
イーピーエス株式会社(EPS Co., Ltd.)は、医薬品・医療機器の開発に必要な業務を受託する日本の専門機関です。医薬品・再生医療等製品の開発におけるフルソリューションを提供し、創薬支援から化合物管理まで幅広い専門サービスをワンストップで展開しています。研究開発から製品化までを包括的に支援する業務受託機関(CRO)として位置づけられています。
イーピーエス株式会社は、製薬会社や医療機器メーカー、再生医療関連企業向けに、医薬品・医療機器の開発に必要な業務を受託しています。具体的には創薬支援、化合物管理など、医薬品・再生医療等製品の開発プロセス全体にわたる専門サービスをワンストップで提供し、研究開発から製品化までを包括的に支援しています。
イーピーエス株式会社のサービスは、医薬品・医療機器の研究開発を行う組織によって利用されています。具体的には、製薬会社、医療機器メーカー、再生医療関連企業などが主な対象であり、これらの組織が研究開発から製品化までのプロセスにおいて同社の業務受託サービスを活用しています。
イーピーエス株式会社 (EPS Co., Ltd.) scores 18/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
イーピーエス株式会社 (EPS Co., Ltd.) has a weak AI-visibility profile at 18/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (27/100) and its weakest is trust (12/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,832,626 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 34/100 and thin schema.org structured data. In a live check, Claude could already identify イーピーエス株式会社 (EPS Co., Ltd.) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to イーピーエス株式会社 (EPS Co., Ltd.): 株式会社サクラクレパス (Sakura Color Products Corporation) (37/100), Converge International (37/100), フィガロ技研 (Figaro Engineering) (37/100), FitForTravel (37/100).
A step up - brands to learn from: Word of Mouth Technology (56/100), Werskincare (56/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.